Optimizing cellular immunity against HIV-1 Gag and preventing suppression by HIV-1 gp120

被引:0
作者
van Montfort, Thijs [1 ]
Sanders, Rogier W. [1 ,2 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Lab Expt Virol, Dept Med Microbiol, NL-1012 WX Amsterdam, Netherlands
[2] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA
基金
欧洲研究理事会;
关键词
CD8 T-cell responses; Env; Gag; HIV-1; suppression; vaccine; PHASE-I TRIAL; DOUBLE-BLIND; NYVAC-C; VACCINE; INFECTION; DNA; IMMUNOGENICITY; RESPONSES; THAILAND; BREADTH;
D O I
10.1586/ERV.12.102
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
SIV vaccination studies in monkeys have revealed that Env-directed antibodies are critical for protection against virus acquisition, whereas CD8(+) T-cell responses against the Gag and Pal proteins contribute to control of viremia postinfection. However, designing a vaccine that strongly activates both arms of the immune system, is challenging for a variety of reasons, one being interference of Gag and Env responses. Bockl et al. have studied how to optimize CD8 T-cell responses against Gag, Pol and Nef in the presence of Env co-vaccination. Although Env coadministration suppressed anti-Gag CD8(+) responses, this effect could be counteracted by adjusting the molar ratio of the vaccines and by spatial or temporal separation of the Gag and Env antigens. These results demonstrate that optimal induction of antiviral CD8(+) responses requires careful optimization of vaccine design, composition and administration.
引用
收藏
页码:1175 / 1177
页数:3
相关论文
共 20 条
[1]   Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys [J].
Barouch, Dan H. ;
Liu, Jinyan ;
Li, Hualin ;
Maxfield, Lori F. ;
Abbink, Peter ;
Lynch, Diana M. ;
Iampietro, M. Justin ;
SanMiguel, Adam ;
Seaman, Michael S. ;
Ferrari, Guido ;
Forthal, Donald N. ;
Ourmanov, Ilnour ;
Hirsch, Vanessa M. ;
Carville, Angela ;
Mansfield, Keith G. ;
Stablein, Donald ;
Pau, Maria G. ;
Schuitemaker, Hanneke ;
Sadoff, Jerald C. ;
Billings, Erik A. ;
Rao, Mangala ;
Robb, Merlin L. ;
Kim, Jerome H. ;
Marovich, Mary A. ;
Goudsmit, Jaap ;
Michael, Nelson L. .
NATURE, 2012, 482 (7383) :89-U115
[2]   EV01:: A phase I trial in healthy HIV negative volunteers to evaluate a clade CHIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium [J].
Bart, Pierre-Alexandre ;
Goodall, Ruth ;
Barber, Tristan ;
Harari, Alexandre ;
Guimaraes-Walker, Ana ;
Khonkarly, Mona ;
Sheppard, Neil C. ;
Bangala, Yolanda ;
Frachette, Marie-Joelle ;
Wagner, Ralf ;
Liljestrom, Peter ;
Kraehenbuhl, Jean-Pierre ;
Girard, Marc ;
Goudsmit, Jaap ;
Esteban, Mariano ;
Heeney, Jonathan ;
Sattentau, Quentin ;
McCormack, Sheena ;
Babiker, Abdel ;
Pantaleo, Giuseppe ;
Weber, Jonathan .
VACCINE, 2008, 26 (25) :3153-3161
[3]   Altering an Artificial Gagpolnef Polyprotein and Mode of ENV Co-Administration Affects the Immunogenicity of a Clade C HIV DNA Vaccine [J].
Boeckl, Katharina ;
Wild, Jens ;
Bredl, Simon ;
Kindsmueller, Kathrin ;
Koestler, Josef ;
Wagner, Ralf .
PLOS ONE, 2012, 7 (04)
[4]   Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial [J].
Buchbinder, Susan P. ;
Mehrotra, Devon V. ;
Duerr, Ann ;
Fitzgerald, Daniel W. ;
Mogg, Robin ;
Li, David ;
Gilbert, Peter B. ;
Lama, Javier R. ;
Marmor, Michael ;
del Rio, Carlos ;
McElrath, M. Juliana ;
Casimiro, Danilo R. ;
Gottesdiener, Keith M. ;
Chodakewitz, Jeffrey A. ;
Corey, Lawrence ;
Robertson, Michael N. .
LANCET, 2008, 372 (9653) :1881-1893
[5]   VIROLOGICAL AND IMMUNOLOGICAL CHARACTERIZATION OF LONG-TERM SURVIVORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
CAO, YZ ;
QIN, LM ;
ZHANG, LQ ;
SAFRIT, J ;
HO, DD .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (04) :201-208
[6]  
Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404
[7]   An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses [J].
Harari, Alexandre ;
Bart, Pierre-Alexandre ;
Stoehr, Wolfgang ;
Tapia, Gonzalo ;
Garcia, Miguel ;
Medjitna-Rais, Emmanuelle ;
Burnet, Severine ;
Cellerai, Cristina ;
Erlwein, Otto ;
Barber, Tristan ;
Moog, Christiane ;
Liljestrom, Peter ;
Wagner, Ralf ;
Wolf, Hans ;
Kraehenbuhl, Jean-Pierre ;
Esteban, Mariano ;
Heeney, Jonathan ;
Frachette, Marie-Joelle ;
Tartaglia, James ;
McCormack, Sheena ;
Babiker, Abdel ;
Weber, Jonathan ;
Pantaleo, Giuseppe .
JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 205 (01) :63-77
[8]  
Harrer T, 1996, J IMMUNOL, V156, P2616
[9]   X4 Human Immunodeficiency Virus Type 1 gp120 Down-Modulates Expression and Immunogenicity of Codelivered Antigens [J].
Hovav, Avi-Hai ;
Santosuosso, Michael ;
Bivas-Benita, Maytal ;
Plair, Andre ;
Cheng, Alex ;
Elnekave, Mazal ;
Righi, Elda ;
Chen, Tao ;
Kashiwagi, Satoshi ;
Panas, Michael W. ;
Xiang, Shi-Hua ;
Furmanov, Karina ;
Letvin, Norman L. ;
Poznansky, Mark C. .
JOURNAL OF VIROLOGY, 2009, 83 (21) :10941-10950
[10]   HIV vaccine may raise risk [J].
Ledford, Heidi .
NATURE, 2007, 450 (7168) :325-325